ClinicalTrials.Veeva
Menu

Find clinical trials for Breast Cancer in St Louis, MO

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Triple Negative Breast Cancer
Cancer
Non-Small-Cell Lung Carcinoma
Ovarian Cancer
Neoplasm Metastasis
Squamous Cell Carcinoma of Head and Neck
Endometrial Cancer

Breast Cancer trials near St Louis, MO, USA:

Cryoablation vs Lumpectomy in T1 Breast Cancers (COOL-IT)

This trial studies the efficacy and safety of cryoablation in patients with low risk, early stage breast cancer. Cryoablation is a ...

Enrolling
Breast Cancer
Breast Neoplasm
Device: Endocare SlimLine Cryoprobe
Procedure: Lumpectomy
The Washington University
The Washington University

St Louis, Missouri, United States

The purpose of this study is to find out the possible anti-cancer effect of pelareorep in combination with chemotherapy \[paclitaxel\] and a ...

Active, not recruiting
Breast Cancer Metastatic
Drug: Avelumab
Drug: Paclitaxel

Phase 2

Oncolytics Biotech

Saint Louis, Missouri, United States and 17 other locations

with NECTIN4-amplified recurrent, unresectable, or metastatic breast cancer who have received prior therapy (see inclusion criteria...

Enrolling
Breast Cancer
Drug: Zelenectide pevedotin (BT8009)

Phase 2

BicycleTx

St Louis, Missouri, United States and 38 other locations

A Global, Phase 2 Study of ARX788 in HER2-positive Metastatic Breast Cancer Patients who were previously treated with T-DXd...

Active, not recruiting
HER2 Positive Metastatic Breast Cancer
Drug: ARX788

Phase 2

Ambrx

St Louis, Missouri, United States and 32 other locations

OR in combination with Hormonal Therapy in subjects with HR+, HER2- locally advanced and unresectable (Stage III) or metastatic (Stage IV) breast...

Enrolling
Breast Cancer
Drug: RGT-419B
Drug: RGT-419B in combination with hormonal therapy

Phase 1

Regor Pharmaceuticals

Saint Louis, Missouri, United States and 7 other locations

to anti-HER2-based therapy plus endocrine therapy alone in improving the outcomes of subjects with hormone receptor-positive, HER2+ metastatic breast...

Active, not recruiting
Estrogen Receptor Positive Breast Cancer
HER-2 Positive Breast Cancer
Drug: palbociclib
Drug: trastuzumab

Phase 3

Alliance Foundation Trials

St Louis, Missouri, United States and 107 other locations

medicines for the potential treatment of advanced or metastatic breast cancer.This study is seeking participants who have breast...

Active, not recruiting
Breast Cancer
Drug: ARV-471
Drug: Ribociclib

Phase 1, Phase 2

Pfizer
Pfizer

St Louis, Missouri, United States and 28 other locations

positive (HR+) and human epidermal growth factor 2 negative (HER2-) breast cancer (BC) and other advanced solid tumors. Th...

Enrolling
Hormone-receptor-positive Breast Cancer
Non-small Cell Lung Cancer
Drug: BGB-43395
Drug: Fulvestrant

Phase 1

BeiGene
BeiGene

St Louis, Missouri, United States and 63 other locations

medicines for the potential treatment of advanced or metastatic breast cancer.This study is seeking participants who have breast...

Active, not recruiting
Breast Cancer
Drug: Abemaciclib
Drug: ARV-471

Phase 1, Phase 2

Pfizer
Pfizer

St Louis, Missouri, United States and 39 other locations

with pathology-confirmed HR-positive/HER2-negative metastatic breast cancer (MBC) following progression on or after at least two pr...

Enrolling
Hormone Receptor Positive HER-2 Negative Breast Cancer
Metastatic Breast Cancer
Drug: Alisertib
Drug: Endocrine therapy

Phase 2

Puma Biotechnology
Puma Biotechnology

St Louis, Missouri, United States and 52 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems